Open access
Aug 2026
Elevated Circulating Fibroblast Growth Factor 21 in Lean Type 2 Diabetes: Evidence of Metabolic Dysregulation in the Absence of Adiposity
Circulating FGF21 levels are elevated in lean T2DM and may reflect compensatory upregulation or altered FGF21 signaling rather than confirmed tissue-level resistance, suggesting its potential as a biomarker of metabolic dysfunction in the normal-BMI group.
S. Nafea, Nasir Siddique, S. Abdulqadir et al.
· Kansas journal of medicine · 0 citations